Pulmonx LUNG
NASDAQ LUNG
$1.83 +0.00 (+0.27%)
As of: Oct 21, 2026 · 1:05 PM EDT

Pulmonx (LUNG) Convertible Debt (2020)

Updated

Pulmonx (LUNG) recorded Convertible Debt of $29.75 million in Q3 2020.

Analysis

Pulmonx (LUNG) Convertible Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 254.32 Bn 233.47 Bn 4.88 Bn
2 Abbott Laboratories 177.71 Bn 148.79 Bn 7.27 Bn
3 Danaher 157.46 Bn 141.28 Bn 3.61 Bn
4 Intuitive Surgical 155.01 Bn 134.56 Bn 1.96 Bn
5 Medtronic 121.18 Bn 87.05 Bn 6.34 Bn
6 Stryker 116.77 Bn 102.89 Bn 4.50 Bn
7 Boston Scientific 66.08 Bn 61.09 Bn 3.85 Bn
8 Becton Dickinson 52.79 Bn 49.94 Bn 2.32 Bn
9 Edwards Lifesciences 50.89 Bn 35.01 Bn 1.35 Bn
10 Pulmonx 75.85 Mn -243.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 29.75 Mn
API Access

Pulmonx Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=LUNG&period=max&api_key=YOUR_API_KEY